0001213900-24-028973.txt : 20240401 0001213900-24-028973.hdr.sgml : 20240401 20240401181506 ACCESSION NUMBER: 0001213900-24-028973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240328 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weisblum Eric CENTRAL INDEX KEY: 0001569077 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41512 FILM NUMBER: 24811493 MAIL ADDRESS: STREET 1: 285 GRAND AVENUE CITY: ENGLEWOOD STATE: NJ ZIP: 07631 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Silo Pharma, Inc. CENTRAL INDEX KEY: 0001514183 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 462137136 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 677 N. WASHINGTON BLVD CITY: SARASOTA STATE: FL ZIP: 34236 BUSINESS PHONE: (718) 400-9031 MAIL ADDRESS: STREET 1: 677 N. WASHINGTON BLVD CITY: SARASOTA STATE: FL ZIP: 34236 FORMER COMPANY: FORMER CONFORMED NAME: Uppercut Brands, Inc. DATE OF NAME CHANGE: 20190808 FORMER COMPANY: FORMER CONFORMED NAME: Point Capital, Inc. DATE OF NAME CHANGE: 20130130 FORMER COMPANY: FORMER CONFORMED NAME: Gold Swap Inc DATE OF NAME CHANGE: 20110301 4 1 ownership.xml X0508 4 2024-03-28 0 0001514183 Silo Pharma, Inc. SILO 0001569077 Weisblum Eric C/O SILO PHARMA, INC. 677 N. WASHINGTON BOULEVARD SARASOTA FL 34236 1 1 0 0 CEO and President 0 Common Stock 2024-03-28 4 P 0 3408 1.94 A 173332 D Common Stock 2024-04-01 4 P 0 1100 1.91 A 174432 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.91 to $1.95. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $1.93. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Eric Weisblum 2024-04-01